SimpleTrials, the latest Clinical Trial Management System (CTMS) from Trial By Fire Solutions, has been recognized as one of the Top 10 eClinical Trial Management Solution Providers for 2017 by Pharma Tech Outlook Magazine. SimpleTrials and Trial By Fire Solutions are featured as the cover story for the Top 10 issue in March 2017.nn“We take pride in honoring Trial By Fire Solutions as one of the Top 10 companies specialized in providing eClinical Trial Management solutions” said Stacey Smith, Managing Editor of Pharma Tech Outlook. “The SimpleTrials team gains this recognition for putting their efforts into building a smart and affordable clinical study management solution for today’s market.”
We’re pleased to announce the latest life sciences client to embrace the power of SimpleCTMS! Our newest client is a clinical stage biopharmaceutical company based in the United States whose focus is developing novel immunotherapies for the treatment of cancer and viral infections. They approached Trial By Fire Solutions after core team members had utilized SimpleCTMS at another company in the past with great success.
Trial By Fire Solutions is pleased to announce the launch of SimpleTrials, the first on-demand, cloud-based Clinical Trial Management System (CTMS) focused on assisting sponsors, sites, CROs and other clinical stakeholders with study and portfolio management. This unique CTMS software application offers a secure, feature rich and cost effective solution which can be adopted using a simple online registration process.nMany Life Science companies, CROs and investigative sites have traditionally been priced out of a CTMS. They continue to utilize worksheet trackers that fall short of their needs and often put them at a competitive disadvantage. The introduction of SimpleTrials will break down those cost barriers by offering a robust software application that is affordably priced with no long term commitment and can be easily scaled up or down as the study needs require.
Trial By Fire Solutions, LLC, a leading eClinical solution provider, announced today that Pearl Therapeutics, Inc., a US based biopharmaceutical company, has selected SimpleCTMS as their CTMS vendor to optimize the management of their global clinical studies.nThe initial Pearl deployment includes multiple Phase II global studies in which SimpleCTMS will be deployed for study startup planning and ongoing study tracking. SimpleCTMS will improve data transparency across service providers, and integrate with other key eClinical systems utilized by Pearl.
Trial by Fire Solutions LLC, a leading eClinical solution provider, has announced 2 new agreements with a US-based drug developer and a CRO subsidiary of an S&P 500 firm to utilize SimpleCTMS to optimize management of their respective global clinical studies.nThe drug development company will initially deploy SimpleCTMS for 4 Phase II global studies with over 500 subjects planned. It will bridge the outsourced teams and connect global service providers while enabling immediate data visibility across all study components. The CRO subsidiary will incorporate SimpleCTMS as part of a suite of platformed services used to optimize clinical research opportunities.